For decades, we have assumed that all regulated cell death pathways have a dedicated “point of no return” that precedes death but after which cells are committed to die. The realization that this is often not the case represents what can be considered a paradigm shift in the field. Here we consider how cells can survive despite engagement of a cell death pathway and the consequences of a “near death experience” in cancer cells and possibly other physiological conditions.
No takes yet. Share an insight, caveat, or question.
Douglas R. Green (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: